Search Results - 10F.9G2 antibody

Avelumab Biosimilar, Anti-human PD-L1 Antibody | C023P

Avelumab Biosimilar, Human PD-L1 Monoclonal Antibody. The research grade Avelumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be...

Camrelizumab Biosimilar, Anti-human PD-1 Antibody | C028P

Camrelizumab Biosimilar, PD-1 Monoclonal Antibody. The research grade Camrelizumab biosimilar protein is for research use only (RUO). Recombinant human IgG4 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...

Anti-Mouse PD-L1 Monoclonal Antibodies (10F.9G2)

The rat anti-mouse PD-L1 antibody is produced by the hybridoma clone 10F.9G2. The rat anti-mouse PDL1 monoclonal antibody has been sequenced and converted to recombinant or chimeric mouse anti-mouse PD L1 antibodies. The recombinant 10F.9G2...

Anti-Mouse PD-1 Monoclonal Antibodies (29F.1A12)

The anti-mouse PD-1 antibody is produced by the hybridoma clone 29F.1A12. The rat anti-mouse PD 1 monoclonal antibody has been sequenced and converted to recombinant or chimeric mouse anti-mouse PD1 antibodies. The recombinant 29F.1A12 antibodies...

Recombinant Anti-mouse PD-1 Monoclonal Antibody (Clone RMP1-14.1), Mouse IgG2a Kappa | PA007162.m2a Ushelf

Anti-mouse PD-1 (CD279)-InVivo | PA007162.m2a

Recombinant Anti-mouse PD-1 Mouse IgG2a Kappa Monoclonal Antibody (Clone RMP1-14.1). Recombinant mouse anti-mouse PD 1 / CD279 monoclonal antibodies, whose variable region sequences are murined from the rat anti-mouse PD-1 monoclonal antibody (clone number: RMP1-14),...

Durvalumab Biosimilar C025P.05 Syd Labs

Durvalumab Biosimilar, Endotoxin 0.05 EU/mg | C025P.05

Durvalumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Durvalumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...